Advancing the regulatory path on hepatitis B virus treatment and curative research: a stakeholders consultation.

about

Post-infection viral superinfection technology could treat HBV and HCV patients with unmet needs

P2860

Q57020823-446D96C4-D773-4EFE-88AC-46C860A6F687

P2860

Advancing the regulatory path on hepatitis B virus treatment and curative research: a stakeholders consultation.

Item

http://www.wikidata.org/entity/Q42318295

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Advancing the regulatory path ...... : a stakeholders consultation.

@en

Advancing the regulatory path ...... : a stakeholders consultation.

@nl

type

Item

label

Advancing the regulatory path ...... : a stakeholders consultation.

@en

Advancing the regulatory path ...... : a stakeholders consultation.

@nl

prefLabel

Advancing the regulatory path ...... : a stakeholders consultation.

@en

Advancing the regulatory path ...... : a stakeholders consultation.

@nl

P1476

Advancing the regulatory path ...... : a stakeholders consultation.

@en

P2093

Carol L Brosgart

http://www.w3.org/2001/XMLSchema#string

Ed G Marins

http://www.w3.org/2001/XMLSchema#string

Eric F Donaldson

http://www.w3.org/2001/XMLSchema#string

Jonathan Liu

http://www.w3.org/2001/XMLSchema#string

Marion G Peters

http://www.w3.org/2001/XMLSchema#string

Oliver Lenz

http://www.w3.org/2001/XMLSchema#string

Pedro Goicochea

http://www.w3.org/2001/XMLSchema#string

Poonam Mishra

http://www.w3.org/2001/XMLSchema#string

Seng Gee Lim

http://www.w3.org/2001/XMLSchema#string

Timothy Block

http://www.w3.org/2001/XMLSchema#string

P2860

Hepatitis delta: epidemiology, diagnosis and management 36 years after discovery

Recent advances in understanding and diagnosing hepatitis B virus infection

Telbivudine versus lamivudine in patients with chronic hepatitis B

Pegylated interferon alfa-2b alone or in combination with lamivudine for HBeAg-positive chronic hepatitis B: a randomised trial

Estimations of worldwide prevalence of chronic hepatitis B virus infection: a systematic review of data published between 1965 and 2013.

Comparison of serum HBsAg quantitation by four immunoassays, and relationships of HBsAg level with HBV replication and HBV genotypes.

World-wide epidemiology of HBeAg-negative chronic hepatitis B and associated precore and core promoter variants.

Efficacy of neonatal HBV vaccination on liver cancer and other liver diseases over 30-year follow-up of the Qidong hepatitis B intervention study: a cluster randomized controlled trial.

Risk for hepatocellular carcinoma in the course of chronic hepatitis B virus infection and the protective effect of therapy with nucleos(t)ide analogues

The laboratory diagnosis of hepatitis B virus.

P304

1-6

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

editorial

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28275452

http://www.w3.org/2001/XMLSchema#string

P932

5337416

http://www.w3.org/2001/XMLSchema#string

Advancing the regulatory path on hepatitis B virus treatment and curative research: a stakeholders consultation.

about

P2860

P2860

Advancing the regulatory path on hepatitis B virus treatment and curative research: a stakeholders consultation.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P433

P478

P577

P698

P932

P1433

P1476

P2093

P2860

P304

P31

P433

P478

P577

P698

P932